Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02555189
Title	Enzalutamide With and Without Ribociclib for Metastatic, Castrate-Resistant, Chemotherapy-Naive Prostate Cancer That Retains RB Expression
Recruitment	Completed
Gender	male
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Sidney Kimmel Cancer Center at Thomas Jefferson University
Indications	prostate cancer
Therapies	Ribociclib Enzalutamide
Age Groups:	adult \| senior
Covered Countries	USA